Ben Gil Price - 03 Nov 2021 Form 4 Insider Report for NeuroBo Pharmaceuticals, Inc. (MTVA)

Role
CEO and President
Signature
/s/ Ben Gil Price
Issuer symbol
MTVA
Transactions as of
03 Nov 2021
Net transactions value
$0
Form type
4
Filing time
04 Nov 2021, 16:57:38 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NRBO Nonstatutory Stock Option (right to buy) Award $0 +616,666 $0.000000 616,666 03 Nov 2021 Common Stock 616,666 $2.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 266,666 shares subject to the option vest on the first anniversary of the vesting commencement date, November 3, 2021, and the remaining 350,000 shares subject to the option vest on the second anniversary of the vesting commencement date, subject to the Reporting Person's continuous service.